Skip to Main Content

Author Details

Alan Pollack
University of Miami Miller School of Medicine
1963
385
70
PMIDPaper TitleJournal TitlePublished Year
36459380A latent class analysis of health behavior changes after cancer diagnosis among Hispanic/Latino cancer survivors.J Cancer Surviv2024
37990759Uncovering prostate cancer aggressiveness signal in T2-weighted MRI through a three-reference tissues normalization technique.NMR Biomed2024
36596347Analysis of a Biopsy-Based Genomic Classifier in High-Risk Prostate Cancer: Meta-Analysis of the NRG Oncology/Radiation Therapy Oncology Group 9202, 9413, and 9902 Phase 3 Randomized Trials.Int J Radiat Oncol Biol Phys2023
37958414Clinical-Genomic Risk Group Classification of Suspicious Lesions on Prostate Multiparametric-MRI.Cancers (Basel)2023
37514162Targeted Bioluminescent Imaging of Pancreatic Ductal Adenocarcinoma Using Nanocarrier-Complexed EGFR-Binding Affibody-Gaussia Luciferase Fusion Protein.Pharmaceutics2023
35521917Experimental Support for the Possibility of Retrograde Genesis of Intraductal Carcinoma of the Prostate.Int J Surg Pathol2023
37190264Classifying Malignancy in Prostate Glandular Structures from Biopsy Scans with Deep Learning.Cancers (Basel)2023
37468066Radiation nephropathy: Mechanisms of injury and recovery in a murine model.Radiother Oncol2023
37205576Radiogenomic profiling of prostate tumors prior to external beam radiotherapy converges on a transcriptomic signature of TGF-β activity driving tumor recurrence.medRxiv2023
36998445<i>In vivo</i> active-targeting fluorescence molecular imaging with adaptive background fluorescence subtraction.Front Oncol2023
36522269Distinct Profiles of DNA Repair Activity Define Favorable-risk Prostate Cancer Subtypes With Divergent Outcome.Clin Genitourin Cancer2023
36566906Long-Term Results of a Phase 3 Randomized Prospective Trial of Erectile Tissue-Sparing Intensity-Modulated Radiation Therapy for Men With Clinically Localized Prostate Cancer.Int J Radiat Oncol Biol Phys2023
34016556Integrating Prostate-specific Antigen Kinetics into Contemporary Predictive Nomograms of Salvage Radiotherapy After Radical Prostatectomy.Eur Urol Oncol2022
35671868Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer.Int J Radiat Oncol Biol Phys2022
35636621Validation of the Decipher genomic classifier in patients receiving salvage radiotherapy without hormone therapy after radical prostatectomy - an ancillary study of the SAKK 09/10 randomized clinical trial.Ann Oncol2022
35569466The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial.Lancet2022
36558293Boosted Radiation Bystander Effect of PSMA-Targeted Gold Nanoparticles in Prostate Cancer Radiosensitization.Nanomaterials (Basel)2022
36175971Assessment of IMPT versus VMAT plans using different uncertainty scenarios for prostate cancer.Radiat Oncol2022
36139635Longitudinal Changes and Predictive Value of Multiparametric MRI Features for Prostate Cancer Patients Treated with MRI-Guided Lattice Extreme Ablative Dose (LEAD) Boost Radiotherapy.Cancers (Basel)2022
36297640Quantifying Radiosensitization of PSMA-Targeted Gold Nanoparticles on Prostate Cancer Cells at Megavoltage Radiation Energies by Monte Carlo Simulation and Local Effect Model.Pharmaceutics2022
36094323SMPDL3b modulates radiation-induced DNA damage response in renal podocytes.FASEB J2022
36116477The addition of pelvic lymph node treatment to prostate bed salvage radiotherapy - Authors' reply.Lancet2022
35022600Clinicogenomic characterization of prostate cancer liver metastases.Prostate Cancer Prostatic Dis2022
34669939Anterior or Posterior Prostate Cancer Tumor Nodule Location Predicts Likelihood of Certain Adverse Outcomes at Radical Prostatectomy.Arch Pathol Lab Med2022
33356482Heterogeneity in Genomic Risk Assessment from Tissue Based Prognostic Signatures Used in the Biopsy Setting and the Impact of Magnetic Resonance Imaging Targeted Biopsy.J Urol2021
33598943Repeatability of CBCT radiomic features and their correlation with CT radiomic features for prostate cancer.Med Phys2021
33570548Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer: An Ancillary Study of the NRG/RTOG 9601 Randomized Clinical Trial.JAMA Oncol2021
34972513A personalized decision aid for prostate cancer shared decision making.BMC Med Inform Decis Mak2021
34926886Interactions of Urea-Based Inhibitors with Prostate-Specific Membrane Antigen for Boron Neutron Capture Therapy.ACS Omega2021
34551377Novel genomic signature predictive of response to immune checkpoint blockade: A pan-cancer analysis from project Genomics Evidence Neo-plasia Information Exchange (GENIE).Cancer Genet2021
34722812Assessment of Knowledge-Based Planning for Prostate Intensity Modulated Proton Therapy.Int J Part Ther2021
34184782Percentage of Gleason pattern 4 and tumor volume predict adverse pathological stage and margin status at radical prostatectomy in grade Group 2 and grade Group 3 prostate cancers.Prostate2021
33964351Prostate Cancer Targeted X-Ray Fluorescence Imaging via Gold Nanoparticles Functionalized With Prostate-Specific Membrane Antigen (PSMA).Int J Radiat Oncol Biol Phys2021
33464992Noninvasive assessment of radiation-induced renal injury in mice.Int J Radiat Biol2021
33445124Assessment of daily dose accumulation for robustly optimized intensity modulated proton therapy treatment of prostate cancer.Phys Med2021
33419682The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory Revisited.Eur Urol2021
32221622Segmentation of prostate and prostate zones using deep learning : A multi-MRI vendor analysis.Strahlenther Onkol2020
32084522Phase I Trial of MRI-Guided Prostate Cancer Lattice Extreme Ablative Dose (LEAD) Boost Radiation Therapy.Int J Radiat Oncol Biol Phys2020
32862068Margin verification for hypofractionated prostate radiotherapy using a novel dose accumulation workflow and iterative CBCT.Phys Med2020
32821953The role of radiomics in prostate cancer radiotherapy.Strahlenther Onkol2020
32366674Radiation Attenuates Prostate Tumor Antiviral Responses to Vesicular Stomatitis Virus Containing IFNβ, Resulting in Pronounced Antitumor Systemic Immune Responses.Mol Cancer Res2020
32119599Ten-Year Update of a Randomized, Prospective Trial of Conventional Fractionated Versus Moderate Hypofractionated Radiation Therapy for Localized Prostate Cancer.J Clin Oncol2020
32231245Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier.Prostate Cancer Prostatic Dis2020
32424273Using hormone therapy with salvage radiotherapy according to presalvage PSA levels.Nat Rev Urol2020
30553614Local Treatment in Metastatic Prostate Cancer: A Cultural Shift Confronts Power and Selection.Eur Urol2019
30140944Towards a universal MRI atlas of the prostate and prostate zones : Comparison of MRI vendor and image acquisition parameters.Strahlenther Onkol2019
30836166Dose Escalation for Prostate Adenocarcinoma: A Long-Term Update on the Outcomes of a Phase 3, Single Institution Randomized Clinical Trial.Int J Radiat Oncol Biol Phys2019
31007853Erratum: Predicting clinically significant prostate cancer using DCE-MRI habitat descriptors.Oncotarget2019
29128208Multi-institutional Evaluation of Elective Nodal Irradiation and/or Androgen Deprivation Therapy with Postprostatectomy Salvage Radiotherapy for Prostate Cancer.Eur Urol2018
30050803Magnetic resonance imaging (MRI)-based radiomics for prostate cancer radiotherapy.Transl Androl Urol2018
  • 1 - 50 of 385

Recommended Authors

Rachel M Glicksman
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Career Start Year 2013
Number of shared co-authors 21
Xin Pei
Memorial Sloan Kettering Cancer Center
Career Start Year 2010
Number of shared co-authors 3
Suneil Jain
Cancer Centre Belfast City Hospital, Queen's University Belfast
Career Start Year 2008
Number of shared co-authors 17
Jure Murgic
University Hospital Center Sestre Milosrdnice
Career Start Year 2008
Number of shared co-authors 9
John Thoms
Memorial University
Career Start Year 2008
Number of shared co-authors 7
Nicholas van As
The Institute of Cancer Research, Royal Marsden NHS Foundation Trust
Career Start Year 2005
Number of shared co-authors 7
Nicholas G Nickols
University of California, Veteran Affairs Greater Los Angeles Healthcare System
Career Start Year 2003
Number of shared co-authors 60
Chandana A Reddy
Cleveland Clinic
Career Start Year 2000
Number of shared co-authors 29
Allison Steigler
University of Newcastle
Career Start Year 1999
Number of shared co-authors 28
Daniel J Krauss
William Beaumont School of Medicine
Career Start Year 1999
Number of shared co-authors 32
Wolfgang Lilleby
Oslo University Hospital
Career Start Year 1999
Number of shared co-authors 26
Danny Y Song
Johns Hopkins University School of Medicine
Career Start Year 1999
Number of shared co-authors 47
Danny Vesprini
University of Toronto, Canada Odette Cancer Centre
Career Start Year 1998
Number of shared co-authors 10
Gert De Meerleer
University Hospitals Leuven
Career Start Year 1997
Number of shared co-authors 25
Brian J Davis
Mayo Clinic
Career Start Year 1997
Number of shared co-authors 46
Laurence Collette
Belgium International Drug Development Institute
Career Start Year 1995
Number of shared co-authors 18
Andrew Loblaw
Princess Margaret Hospital, University of Toronto
Career Start Year 1995
Number of shared co-authors 28
Jay P Ciezki
Cleveland Clinic
Career Start Year 1995
Number of shared co-authors 33
Almudena Zapatero
University Hospital La Princesa
Career Start Year 1995
Number of shared co-authors 35
Jonathan D Tward
Huntsman Cancer Institute, University of Utah
Career Start Year 1994
Number of shared co-authors 36
Xavier Maldonado
Hospital Universitari Vall d'Hebron
Career Start Year 1994
Number of shared co-authors 24
Richard Choo
Mayo Clinic
Career Start Year 1991
Number of shared co-authors 25
David Joseph
Sir Charles Gairdner Hospital
Career Start Year 1990
Number of shared co-authors 29
Christopher P Evans
University of California Davis
Career Start Year 1988
Number of shared co-authors 27
Celestia S Higano
University of Washington and Fred Hutchinson Cancer Research Center
Career Start Year 1987
Number of shared co-authors 28
Alan W Partin
The Brady Urological Institute, Johns Hopkins University School of Medicine
Career Start Year 1987
Number of shared co-authors 31
Peter Hoskin
Mount Vernon Cancer Centre
Career Start Year 1985
Number of shared co-authors 34
Maha Hussain
Northwestern University
Career Start Year 1984
Number of shared co-authors 35
James W Denham
University of Newcastle
Career Start Year 1980
Number of shared co-authors 28
Michel Bolla
universite Grenoble-Alpes (UGA)
Career Start Year 1971
Number of shared co-authors 22

Collaborators

Eric M Horwitz
Fox Chase Cancer Center
Co-authored papers 68
Alexandra L Hanlon
Virginia Tech
Co-authored papers 40
Mark K Buyyounouski
Stanford University
Co-authored papers 35
Howard M Sandler
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 30
Mack Roach
University of California San Francisco
Co-authored papers 23
Alan Dal Pra
University of Miami Miller School of Medicine
Co-authored papers 20
William Robert Lee
Duke University School of Medicine
Co-authored papers 14
Jeff M Michalski
Washington University School of Medicine
Co-authored papers 14
Thomas M Pisansky
Mayo Clinic
Co-authored papers 13
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers 13
Andre Konski
Chester County Hospital
Co-authored papers 12
Elai Davicioni
Veracyte Inc.
Co-authored papers 12
Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 10
Deborah W Bruner
Emory University, USA Winship Cancer Institute, USA School of Medicine
Co-authored papers 10
Kyle R Padgett
Sylvester Comprehensive Cancer Center, Miller School of Medicine
Co-authored papers 9
Zhaomei Mu
Thomas Jefferson University Hospital
Co-authored papers 9
Colin P Dinney
The University of Texas MD Anderson Cancer Center
Co-authored papers 7
Paul L Nguyen
Brigham and Women's Hospital and Dana Farber Cancer Institute, Harvard Medical School
Co-authored papers 7
Raphael E Pollock
James Cancer Center, The Ohio State University
Co-authored papers 6
Robert B Den
Thomas Jefferson University Hospital
Co-authored papers 6
Brandon A Mahal
Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine
Co-authored papers 5
Seth A Rosenthal
Sutter Cancer Centers Radiation Oncology Services
Co-authored papers 5
Andrew K Lee
Texas Center for Proton Therapy
Co-authored papers 5
Rahul D Tendulkar
Taussig Cancer Institute, Cleveland Clinic
Co-authored papers 5
Adel K El-Naggar
MD Anderson Cancer Center
Co-authored papers 4
Kiri A Sandler
Oregon Health and Science University
Co-authored papers 4
Amar U Kishan
University of California los angeles
Co-authored papers 4
Mohammed Alshalalfa
University of Miami Miller School of Medicine/Sylvester Comprehensive Cancer Center
Co-authored papers 4
Drew Moghanaki
University of California Los Angeles
Co-authored papers 4
Bridget F Koontz
Duke University School of Medicine
Co-authored papers 4
Release 1.2